Sep 08, 2024
https://www.businesswire.com/news/home/20240909342829/en/Candid-Therapeutics-Debuts-with-370M-Capital-Raise-to-Clinically-Evaluate-Potentially-Transformative-Autoimmune-Therapies/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT
Fairmount Partners Investment Banking has invested $370M in Candid Therapeutics, Inc.